Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 Months
Clinical trial NCT03704740 · COMPLETED
Trial details
- NCT number
- NCT03704740
- Sponsor
- SK Bioscience Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-25
- Primary completion
- 2019-07-12
- Enrollment
- 676
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.